glp-1 gastric intestinal obstruction legal team in louisiana gi lawsuit GLP-1 receptor agonists are increasingly used to treat Patients claim blindness, bowel injuries
Description
#glp1 #lawsuit #weightloss | NewsNation
The study protocol received approval from the Institutional Review Board at the University of Florida, USA (Approval code: IRB201900262)
Ros Body Program also includes medical evaluation, and eligible users may receive a prescription for a GLP-1 medication such as semaglutide
Please reach out to the authors, your Foley relationship partner, or to our Health Care Practice Group and Health Care & Life Sciences Sector with any questions.
Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F
